FAITH COON: Open Payments
NPI 1740939974 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 33 payments from 17 companies in 2025. Trend: 2023 $37 · 2024 $228 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $129 |
| SANOFI-AVENTIS U.S. LLC | 4 | $112 |
| Corcept Therapeutics | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Amgen Inc. | 2 | $50 |
| Sequel Med Tech, LLC | 1 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Soleno Therapeutics, Inc. | 1 | $30 |
| Radius Health, Inc. | 1 | $27 |
Products named: TZIELD, Ozempic, Korlym, JARDIANCE, TEPEZZA, TWIIST, Kerendia, MOUNJARO.
Industry payments across TX — which companies pay providers there.
